Wolfram Ruf News Today

Two recent studies have analyzed the blood of patients with long COVID, aiming to unravel the mysteries surrounding its development.

New research provides more evidence on how SARS-CoV-2 affects the immune system and blood clotting pathways, and could pave the way for treatment.

A shifting pattern of proteins, showing immune dysregulation, could help efforts to create diagnostic tests and treatment. 

Two recent studies have analyzed the blood of patients with long COVID, aiming to unravel the mysteries surrounding its development with the hope of directing diagnostic and therapeutic research.

A shifting pattern of proteins, showing immune dysregulation, could help efforts to create diagnostic tests and treatment. 

An team of scientists has found distinct changes in the blood of people with long COVID, suggesting a potential strategy to diagnose and perhaps treat the condition.

These findings, which include potential biomarkers and new treatment strategies, provide a promising direction for future diagnostic and therapeutic research.

A shifting pattern of proteins, showing immune dysregulation, could help efforts to create diagnostic tests and treatment. 

<p>Analysis of blood samples from patients with Long Covid – a debilitating condition with unknown causes – has revealed serum protein changes as the likely culprit. The findings highlight potential biomarkers for Long Covid diagnosis and could yield insights into treating the condition. Not everyone fully recovers from COVID-19. Roughly 20% of patients diagnosed with it and about 5% of all SARS-CoV-2–infected persons develop lingering symptoms, called Long Co...

A shifting pattern of proteins, showing immune dysregulation, could help efforts to create diagnostic tests and treatment.